Objective
Clinical studies (CS) are crucial for improving healthcare, but they often fail to include people from all backgrounds. This means the results may not fully reflect how diseases, treatments, and preventative care affect everyone, especially groups that are often left out, such as those from different cultural, economic, gender, sexual, and age groups. These underserved (US) and underrepresented (UR) communities face barriers to participating in clinical studies, such as living far from study locations, mistrust of the healthcare system, poor communication, and discrimination.
The READI project aims to address these challenges by building a stronger, more connected system for clinical studies. This includes linking researchers, healthcare providers, and patient communities more effectively. READI will provide training, tools, and strategies to help include US and UR patients in clinical studies and develop a digital platform where patients can easily find study information, access tools, and connect with communities involved in the project.
Background Rationale
Clinical studies (CS) are essential for discovering new treatments and improving healthcare for everyone. However, these studies often don’t include people from all backgrounds, which means the results may not apply to everyone equally. This is a big issue because it leaves gaps in our understanding of how diseases and treatments affect different groups, such as people from various cultural, economic, gender, and age groups, or those facing healthcare inequalities.
Many underserved (US) and underrepresented (UR) communities encounter challenges that prevent them from participating in clinical studies. These challenges include living far away from study sites, mistrusting the healthcare system, a lack of clear communication, and experiences of discrimination.
To address this problem, the READI project is focused on creating a better, more inclusive system for clinical studies. By connecting researchers, healthcare providers, and patients more effectively, and by providing new tools and resources, READI aims to break down barriers and make clinical studies more accessible to everyone. This approach will ensure healthcare advancements benefit people from all walks of life
Description of Project
Clinical studies (CS) are crucial for improving healthcare, but they often fail to include people from all backgrounds. This means the results may not fully reflect how diseases, treatments, and preventative care affect everyone, especially groups that are often left out, such as those from different cultural, economic, gender, sexual, and age groups. These underserved (US) and underrepresented (UR) communities face barriers to participating in clinical studies, such as living far from study locations, mistrust of the healthcare system, poor communication, and discrimination.
The READI project aims to address these challenges by building a stronger, more connected system for clinical studies. This includes linking researchers, healthcare providers, and patient communities more effectively. READI will provide training, tools, and strategies to help include US and UR patients in clinical studies and develop a digital platform where patients can easily find study information, access tools, and connect with communities involved in the project.
The project will test these solutions in at least four real-world clinical studies to see how well they work.
READI brings together 69 organizations from 17 countries, including experts in clinical research, patient engagement, digital technology, training, communication, and ethics. This collaboration ensures the project will make a meaningful difference in making clinical studies more inclusive and accessible to everyone.
Anticipated Outcome
The READI project aims to make clinical studies more inclusive and accessible to everyone, especially underserved and underrepresented communities. By providing better tools, training, and communication strategies, READI will ensure more diverse participation in clinical studies.
The project will also create an innovative digital platform to help patients easily find information about clinical studies, connect with resources, and engage with supportive communities. By testing these solutions in real-world clinical studies, READI will show how they can improve diversity and participation.
Ultimately, the project will lead to more representative clinical studies, better healthcare solutions for all groups, and a stronger connection between patients, researchers, and healthcare providers. This will help ensure that advances in medicine work for everyone, regardless of their background or circumstances.
Relevance to T1D
The READI project is particularly relevant to Type 1 diabetes (T1D) because this condition affects a diverse range of individuals across various demographics, yet clinical studies often fail to include a representative sample of patients. This lack of diversity in research can limit our understanding of how T1D treatments and prevention strategies work for different populations.
Underserved and underrepresented groups, including children, ethnic minorities, and those from socioeconomically disadvantaged backgrounds, may face barriers such as limited access to study sites, mistrust of the healthcare system, and insufficient communication about study opportunities. These challenges can prevent their participation in T1D clinical research, leading to gaps in knowledge about disease management and treatment effectiveness in these populations.
Through its focus on improving access, communication, and engagement, READI can help ensure that T1D clinical studies are more inclusive. The tools, training, and digital platform developed by READI will empower researchers and healthcare providers to better connect with all T1D patients, fostering diversity in research. This will ultimately lead to more equitable healthcare advancements, ensuring that new treatments, technologies, and prevention methods are effective and accessible for everyone living with T1D